Skip to main content
. 2016 May 2;11(5):e0154023. doi: 10.1371/journal.pone.0154023

Fig 2. Inhibition curve of pulchrin A and cisplatin on ovarian cancer cell lines (CAOV-3 and SKOV-3) for 24, 48 and 72 h.

Fig 2